STEPHANY SIPE: Open Payments
NPI 1336537026 · DEMOTTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 37 payments from 13 companies in 2025. Trend: 2023 $17 · 2024 $255 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $151 |
| Axsome Therapeutics, Inc. | 5 | $141 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $104 |
| ABBVIE INC. | 4 | $85 |
| Exact Sciences Corporation | 2 | $33 |
| Amgen Inc. | 2 | $31 |
| Novo Nordisk Inc | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
Products named: Kerendia, Auvelity, XIFAXAN, QULIPTA, VRAYLAR, Cologuard Collection Kit, OTEZLA, CAPLYTA.
Industry payments across IN — which companies pay providers there.
